BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12839045)

  • 1. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures.
    Nielsen CD; Killip D; Spencer WH
    Clin Cardiol; 2003 Jun; 26(6):275-9. PubMed ID: 12839045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
    Chang SM; Nagueh SF; Spencer WH; Lakkis NM
    J Am Coll Cardiol; 2003 Jul; 42(2):296-300. PubMed ID: 12875767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Ommen SR; Lakkis NM; Killip D; Zoghbi WA; Schaff HV; Danielson GK; Quiñones MA; Tajik AJ; Spencer WH
    J Am Coll Cardiol; 2001 Nov; 38(6):1701-6. PubMed ID: 11704383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; He ZX; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Roberts R; Verani MS; Kleiman NS; Spencer WH
    J Am Coll Cardiol; 1998 Jul; 32(1):225-9. PubMed ID: 9669274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results.
    Oomman A; Ramachandran P; Subramanyan K; Kalarickal MS; Osman MN
    J Invasive Cardiol; 2001 Jul; 13(7):526-30. PubMed ID: 11435640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
    Nagueh SF; Lakkis NM; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Spencer WH
    J Am Coll Cardiol; 1999 Oct; 34(4):1123-8. PubMed ID: 10520801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy.
    Shamim W; Yousufuddin M; Wang D; Henein M; Seggewiss H; Flather M; Coats AJ; Sigwart U
    N Engl J Med; 2002 Oct; 347(17):1326-33. PubMed ID: 12397190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.
    Knight C; Kurbaan AS; Seggewiss H; Henein M; Gunning M; Harrington D; Fassbender D; Gleichmann U; Sigwart U
    Circulation; 1997 Apr; 95(8):2075-81. PubMed ID: 9133518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Honek T
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy.
    Reinhard W; Ten Cate FJ; Scholten M; De Laat LE; Vos J
    Am J Cardiol; 2004 Apr; 93(8):1064-6. PubMed ID: 15081461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up.
    Lakkis NM; Nagueh SF; Dunn JK; Killip D; Spencer WH
    J Am Coll Cardiol; 2000 Sep; 36(3):852-5. PubMed ID: 10987610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy.
    Boekstegers P; Steinbigler P; Molnar A; Schwaiblmair M; Becker A; Knez A; Haberl R; Steinbeck G
    J Am Coll Cardiol; 2001 Sep; 38(3):846-53. PubMed ID: 11527644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.